ROBERT S. FISHMAN - 01 Feb 2022 Form 4 Insider Report for 4D Molecular Therapeutics Inc. (FDMT)

Role
Chief Medical Officer
Signature
/s/ August J. Moretti, Attorney-in-Fact for Robert Fishman
Issuer symbol
FDMT
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 Feb 2022, 16:39:07 UTC
Next filing
06 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 01 Feb 2022 Common Stock 65,000 $15.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.